Clinical Trial Update: Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating early induction with adalimumab for inflammatory arthritis associated with immune checkpoint inhibitor therapy. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Tom Appleton | Conditions: Inflammatory Arthritis, Immune-related Adverse Event | Phase 2 | Status: RECRUITING